Rep. Eshoo Opening Remarks at Health Subcommittee on FDA
May 22, 2024
May 22, 2024
WASHINGTON, May 22 -- Rep. Anna G. Eshoo, D-California, issued the following news release:
Ranking Member Anna G. Eshoo (CA-16) made the following opening statement at the House Committee on Energy and Commerce Health Subcommittee hearing on FDA Regulations of Drugs, Biologics, and Devices:
"Good morning, colleagues. Today we welcome leaders from the Food and Drug Administration (FDA) to discuss the work of the Center for Drug Evaluation and Research, the Center fo . . .
Ranking Member Anna G. Eshoo (CA-16) made the following opening statement at the House Committee on Energy and Commerce Health Subcommittee hearing on FDA Regulations of Drugs, Biologics, and Devices:
"Good morning, colleagues. Today we welcome leaders from the Food and Drug Administration (FDA) to discuss the work of the Center for Drug Evaluation and Research, the Center fo . . .